Home
Conditions
Pharyngeal Neoplasms

Clinical trial condition

Pharyngeal Neoplasms

Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

734 public trials 231 recruiting studies

Refine in advanced search Browse all conditions

Pharyngeal Neoplasms trial results

Completed

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

NCT03715946

Conditions: Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck, +14 more
Locations: Winship Cancer Institute @ Emory University Hospital Midtown Atlanta, Georgia, United States

Providence Cancer Institute Portland, Oregon, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

NCT02281955

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations: University of Florida Gainesville, Florida, United States

University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States

Pardee Memorial Hospital Hendersonville, North Carolina, United States

High Point Regional Health High Point, North Carolina, United States

View Trial Details

Completed

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT05292027

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sichuan Cancer Hospital Chengdu, Sichuan, China

View Trial Details

Completed

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

NCT04996758

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, China

View Trial Details

Completed

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

NCT02538510

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer

NCT06701058

Conditions: Biomarker in Early Diagnosis, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations: Helsinki University Central Hospital Helsinki, Uusimaa, Finland

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions: Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations: Sarcoma Oncology Research Center Santa Monica, California, United States

University of Colorado Denver Aurora, Colorado, United States

University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 14 locations

View Trial Details

Completed

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

NCT01530997

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations: Penrose Cancer Center Colorado Springs, Colorado, United States

University of Florida, Department of Radiation Oncology Gainesville, Florida, United States

University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States

Rex Healthcare Raleigh, North Carolina, United States

View Trial Details

Completed

Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma

NCT06676293

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Chang Gung Memorial Hospital Taoyuan City, Taiwan

View Trial Details

Completed

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

NCT02113878

Conditions: Cancer of Nasopharynx, Carcinoma, Carcinoma of Larynx, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Pharyngeal Neoplasms

Pharyngeal Neoplasms trial results

Related conditions